PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer

Xiaoting Li(Tongji Hospital), Qinglei Gao(Tongji Hospital)
npj Precision Oncology
June 9, 2021
Cited by 57


Related Papers